46,xy Sex Reversal 2, also known as dosage-sensitive sex reversal, is related to difference of sex development and 46,xx sex reversal 1. An important gene associated with 46,xy Sex Reversal 2 is NR0B1 (Nuclear Receptor Subfamily 0 Group B Member 1), and among its related pathways/superpathways are Metapathway biotransformation Phase I and II and Diseases of glycosylation. Affiliated tissues include ovary and testis, and related phenotypes are sex reversal and Increased shRNA abundance (Z-score > 2)